临床医药文献电子杂志
臨床醫藥文獻電子雜誌
림상의약문헌전자잡지
Journal of Clinical Medical Literature (ElectronicEdition)
2014年
13期
2405-2405,2408
,共2页
小儿消化不良性腹泻%布拉酵母菌散剂%常规疗法%疗效对比
小兒消化不良性腹瀉%佈拉酵母菌散劑%常規療法%療效對比
소인소화불량성복사%포랍효모균산제%상규요법%료효대비
Saccharomyces boulardii%Pediatric diarrhea indigestion powders%Conventional therapy%Contrast%Effect
目的:分析个探讨儿科临床上采用布拉酵母菌散剂治疗小儿消化不良性腹泻的疗效及其安全性评价。方法回顾性分析我院2011年1月~2014年1月收治的102例小儿消化不良性腹泻患儿临床资料,采用随机数表的方法将其随机分成两组,对照组51例患者采用临床常规方法继续治疗,主要包括静脉滴注利巴韦林、口服健脾口服液等,观察组51例患儿在此基础上给予布拉酵母菌散剂进行治疗,观察和比较两组患儿的临床疗效。结果观察组患儿在止吐、脱水纠正、大便次数恢复正常、退热、大便性状恢复正常的时间分别为(1.17±0.46)、(1.72±0.69)、(2.47±1.03)、(3.79±0.89)、(4.28±1.31)d,与对照组患儿相比观察组患儿的以上数据均显著要短,差异具有统计学意义(P<0.05);观察组患儿临床治疗的总有效率为94.12%(48/51),对照组患儿临床治疗的总有效率为82.35%(42/51),两组数据差异具有统计学意义(P<0.05)。结论本研究结果表明,儿科临床上采用布拉酵母菌散剂治疗小儿消化不良性腹泻的疗效显著,能显著缩短患儿疾病的主要临床症状,改善和提高患儿的生活质量。
目的:分析箇探討兒科臨床上採用佈拉酵母菌散劑治療小兒消化不良性腹瀉的療效及其安全性評價。方法迴顧性分析我院2011年1月~2014年1月收治的102例小兒消化不良性腹瀉患兒臨床資料,採用隨機數錶的方法將其隨機分成兩組,對照組51例患者採用臨床常規方法繼續治療,主要包括靜脈滴註利巴韋林、口服健脾口服液等,觀察組51例患兒在此基礎上給予佈拉酵母菌散劑進行治療,觀察和比較兩組患兒的臨床療效。結果觀察組患兒在止吐、脫水糾正、大便次數恢複正常、退熱、大便性狀恢複正常的時間分彆為(1.17±0.46)、(1.72±0.69)、(2.47±1.03)、(3.79±0.89)、(4.28±1.31)d,與對照組患兒相比觀察組患兒的以上數據均顯著要短,差異具有統計學意義(P<0.05);觀察組患兒臨床治療的總有效率為94.12%(48/51),對照組患兒臨床治療的總有效率為82.35%(42/51),兩組數據差異具有統計學意義(P<0.05)。結論本研究結果錶明,兒科臨床上採用佈拉酵母菌散劑治療小兒消化不良性腹瀉的療效顯著,能顯著縮短患兒疾病的主要臨床癥狀,改善和提高患兒的生活質量。
목적:분석개탐토인과림상상채용포랍효모균산제치료소인소화불량성복사적료효급기안전성평개。방법회고성분석아원2011년1월~2014년1월수치적102례소인소화불량성복사환인림상자료,채용수궤수표적방법장기수궤분성량조,대조조51례환자채용림상상규방법계속치료,주요포괄정맥적주리파위림、구복건비구복액등,관찰조51례환인재차기출상급여포랍효모균산제진행치료,관찰화비교량조환인적림상료효。결과관찰조환인재지토、탈수규정、대편차수회복정상、퇴열、대편성상회복정상적시간분별위(1.17±0.46)、(1.72±0.69)、(2.47±1.03)、(3.79±0.89)、(4.28±1.31)d,여대조조환인상비관찰조환인적이상수거균현저요단,차이구유통계학의의(P<0.05);관찰조환인림상치료적총유효솔위94.12%(48/51),대조조환인림상치료적총유효솔위82.35%(42/51),량조수거차이구유통계학의의(P<0.05)。결론본연구결과표명,인과림상상채용포랍효모균산제치료소인소화불량성복사적료효현저,능현저축단환인질병적주요림상증상,개선화제고환인적생활질량。
Objective To analyze the clinical use of a pediatric explore Saccharomyces boulardii powder indigestion diarrhea treatment of pediatric efficacy and safety evaluation. Methods A retrospective analysis of pediatric clinical data in children with diarrhea dyspepsia 102 cases in our hospital from January 2011 to January 2014 admitted to using a random number table method randomly divided into two groups,51 cases were treated with routine clinical the method further treatment,including intravenous ribavirin,an oral spleen oral liquid,the observation group 51 cases of children given on the basis of Saccharomyces boulardii powder treatment,observation and comparison of the two groups of children with clinical treatment effect. Results Of children in the observation group antiemetic,dehydration corrected,normal stool frequency,fever,stool restore normal time was (1.17±0.46),(1.72±0.69),(2.47±1.03),(3.79±0.89),(4.28±1.31) d,compared with children in the control group of children with the observation group were significantly more data to be short,the difference was statistically significant (P<0.05); children with clinical observation group total effective rate 94.12% (48/51),the control group of children with clinical total effective rate was 82.35% (42/51),two sets of data were significantly different,with statistical significance (P<0.05). Conclusion The results of this study indicate that the use of the pediatric clinical treatment of children with diarrhea indigestion powders significant effect Saccharomyces boulardii,can significantly shorten the main clinical symptoms in children with the disease,improve and enhance the quality of life of children.